Significant Ownership of Eventide Asset Management, Llc

Signature - Title
/s/ Peter J. Luiso - Peter J. Luiso, General Counsel
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Eventide Asset Management, Llc.

Notify me when Eventide Asset Management, Llc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Eventide Asset Management, Llc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BBNX Beta Bionics, Inc. Common Stock 11.32% $57.4M 4.86M Eventide Asset Management, LLC Jan 31, 2025
XMTR Xometry, Inc. Class A Common Stock, par value $0.000001 per share 6.72% $66M 3.15M Eventide Asset Management, LLC Dec 31, 2024
Inventiva S.A. Ordinary Shares, nominal value Euro 0.01 per share 6.7% 10.1M Eventide Asset Management, LLC May 9, 2025
MIRM Mirum Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.43% $103M 2.61M Eventide Asset Management, LLC Dec 31, 2024
EVH Evolent Health, Inc. Class A Common Stock, par value $0.01 per share 5.4% $53.2M $18.7M 6.29M +54% Eventide Asset Management, LLC Sep 30, 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share 3.73% $2.21M 1.23M Eventide Asset Management, LLC Dec 31, 2024
NKTR Nektar Therapeutics Common Stock, $0.0001 par value 3.61% $3.26M 6.65M Eventide Asset Management, LLC Dec 31, 2024
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 3.46% $1.82M 2.22M Eventide Asset Management, LLC Dec 31, 2024
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 2% $30.6M 1.36M Eventide Asset Management, LLC Jun 30, 2025
ZNTL Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 0% $0 -$7.12M 0 -100% Eventide Asset Management, LLC Mar 31, 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 0% $0 -$613K 0 -100% Eventide Asset Management, LLC Sep 30, 2025
AURA Aura Biosciences, Inc. Common Stock, par value $0.00001 per share 0% $0 -$22.5M 0 -100% Eventide Asset Management, LLC Mar 31, 2025

Schedules 13D/G Reported by Eventide Asset Management, Llc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.